New Melasma Study Alert!
NEW CLINICAL STUDY REPORT: |
|
|
TARGETING THE DERMIS FOR MELASMA MAINTENANCE TREATMENT |
|
|
We are thrilled to present a summary of a groundbreaking clinical study that sheds light on the potential benefits of dermal targeting therapy for maintaining treatment effects in melasma, a prevalent hyperpigmentary disorder. |
|
|
Scientific Report Summary |
|
|
A recent clinical study, led by Hee Jeong Han et al., has unveiled compelling insights into maintenance strategies aimed at preventing the relapse of melasma post-treatment. The study, registered with Clinical Trial number NCT05710068, delved into the efficacy of dermal targeting therapy to sustain the effects of conventional melasma treatments. |
|
|
"The continuous microneedling RF therapy is beneficial in maintaining the conventional therapy of melasma suggesting the protective effect of dermal targeting therapy in melasma development." |
|
|
Treatment Protocol: Participants underwent a two-month course of traditional therapy, followed by split-face randomized treatment involving ongoing monthly microneedling radiofrequency (RF) treatment on one half of the face for an additional six months. |
|
|
Promising Results: Following the initial treatment phase, all participants exhibited a remarkable 64% reduction in the modified melasma area severity index (mMASI) score. The side treated with RF maintained these improvements, while the untreated side experienced a gradual decrease in luminance, eventually reverting to baseline levels. |
|
|
Implications: The study signifies the potential of continuous microneedling RF therapy to sustain the benefits gained from conventional melasma treatments, emphasizing the importance of targeting the aging dermis in preventing melasma development. Edit the content in this column layout so people engage with your email. |
|
|
This study carries significant implications for the dermatological community, highlighting the potential of dermal targeting therapy not only in controlling symptoms but also in offering long-term maintenance benefits post conventional therapy. The findings underscore the need for innovative treatment strategies within the context of pigmentary disorders linked to photoaging, presenting a compelling argument for a comprehensive shift in melasma treatment protocols. We encourage medical professionals to consider these results when formulating and enhancing melasma treatment protocols, as they signify a pivotal step towards more comprehensive maintenance strategies following initial symptom control. |
|
|
For further details, you can refer to the original article below. | | |
|
|
We believe that this study marks a significant advancement in the understanding and treatment of melasma, and we hope it inspires further exploration and innovation in the field of dermatology. |
|
|
FOR MORE INFORMATION: Sarah Oh | Clinical Educator | ClinicalEdu@BENEV.com Jamie Solorsa | Clinical Studies Coordinator | Jamie@BENEV.com |
|
|
Visit our social accounts   
| |
|
|
|
|
| If you no longer wish to receive this email, change your email preferences here. |
|
|
